Gabapentin, sold under the brand name Neurontin among others, is an anticonvulsant medication primarily used to treat partial seizures and neuropathic...
91 KB (8,927 words) - 05:28, 10 November 2024
gabapentin. It was designed for increased oral bioavailability over gabapentin, and human trials showed it to produce extended release of gabapentin with...
8 KB (648 words) - 21:39, 20 December 2023
United States in 2004. It was developed as a successor to the related gabapentin. It is available as a generic medication. In 2022, it was the 91st most...
99 KB (8,532 words) - 19:22, 17 November 2024
the gabapentin receptor (α2δ subunit), as it is the target of the drugs gabapentin and pregabalin. Clinically used gabapentinoids include gabapentin, pregabalin...
41 KB (4,044 words) - 21:20, 15 November 2024
seizures and severe agitation. Approved: Gabapentin (Neurontin) Gabapentin enacarbil (Horizant, Regnite) Gabapentin Extended-Release (Gralise) Pregabalin...
130 KB (13,432 words) - 06:24, 11 September 2024
used transdermally (applied topically to the skin) in combination with gabapentin and clonidine prepared at a compounding pharmacy. Common side effects...
34 KB (3,282 words) - 17:47, 10 November 2024
Pregabalin (2004) Mirogabalin (2019) (Japan only) Gabapentin (1993) Gabapentin enacarbil (Horizant) (2011) Gabapentin extended release (Gralise) (1996) Gabapentinoids...
70 KB (5,717 words) - 15:00, 6 November 2024
most widely attempted medication is gabapentin, with one case series finding that seven of eight patients on gabapentin showed improvement in attack frequency...
6 KB (616 words) - 22:21, 6 November 2024
Phenibut also binds to and blocks α2δ subunit-containing VDCCs, similarly to gabapentin and pregabalin, and hence is a gabapentinoid. Both (R)-phenibut and (S)-phenibut...
36 KB (2,954 words) - 06:58, 11 November 2024
4-Methylpregabalin Arbaclofen Arbaclofen placarbil Atagabalin Baclofen Gabapentin Gabapentin enacarbil Imagabalin Mirogabalin PD-200,347 PD-217,014 PD-299,685...
181 KB (19,615 words) - 18:14, 6 November 2024